Incyte Corp (NASDAQ:INCY)

CAPS Rating: 2 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Recs

0
Player Avatar pchop123 (79.60) Submitted: 2/23/2013 12:30:55 PM : Outperform Start Price: $21.23 INCY Score: +6.36

more rebound left in the tank

Featured Broker Partners


Advertisement